Physician profile
John J Bauer
NPI 1457391658
$1,935.89
in general payments reported to CMS, 2019-2025
27 companies · $410 in 2025
The $410 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $90.63 · 2021: $345 · 2022: $319 · 2023: $241 · 2024: $342 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $958 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $958.47 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $533.19 | 2021-2025 | Lupron Depot |
| Astellas Pharma US INC | $204.31 | 2019-2022 | |
| Boston Scientific Corporation | $188.95 | 2020-2025 | Spaceoar Vue System - 10ml, Rezum Generator |
| Coloplast Corp | $99.51 | 2021-2025 | Altis |
| Pfizer INC. | $91.38 | 2019-2025 | |
| Allergan, INC. | $86.75 | 2020-2022 | |
| Janssen Biotech, INC. | $85.00 | 2019 | |
| Rochester Medical Corporation | $63.88 | 2022 | |
| Medtronic, INC. | $50.67 | 2022 | |
| Olympus America INC. | $49.96 | 2019-2025 | Itind System |
| Dendreon Pharmaceuticals LLC | $48.98 | 2021-2024 | Provenge |
| C. R. Bard, INC. & Subsidiaries | $45.75 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $42.21 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $35.06 | 2025 | Imfinzi |
| Myriad Genetic Laboratories, INC. | $32.66 | 2024-2025 | Prolaris |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $32.51 | 2025 | Keytruda |
| Tolmar, INC. | $32.10 | 2023 | |
| Antares Pharma, INC. | $30.45 | 2021 | |
| Verity Pharmaceuticals INC. | $28.71 | 2024-2025 | Trelstar |
| Sun Pharmaceutical Industries INC. | $24.21 | 2022 | |
| Angiodynamics, INC. | $21.27 | 2025 | Nanoknife |
| Laborie Medical Technologies Corp. | $20.74 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Progenics Pharmaceuticals, INC. | $19.86 | 2024 | |
| Agiliti Surgical, INC. | $19.44 | 2023 | Trinity, Sonablate |
| Civco Medical Instruments | $18.00 | 2024 | |
| Teleflex LLC | $17.88 | 2024 | Urolift |
| Axonics, INC. | $12.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.